Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma.

Faye, Mame Daro; Easaw, Jacob; De Robles, Paula; Agnihotram, Raman; Torres-Vasquez, Alexander; Lamonde, Frederic; Petrecca, Kevin; Owen, Scott; Panet-Raymond, Valerie; Shenouda, George; Souhami, Luis; Azam, Maryam; Hossain, Bushra; Alkass, Jad; Sabri, Siham; Abdulkarim, Bassam.

Afiliação

Faye MD; Division of Radiation Oncology, Mcgill University Health Centre.
Easaw J; Department of Oncology, Cross Cancer Institute.
De Robles P; Department of Oncology, Cross Cancer Institute.
Agnihotram R; Department of Oncology, McGill University Health Centre Research Institute.
Torres-Vasquez A; Department of Oncology, McGill University Health Centre Research Institute.
Lamonde F; Department of Oncology, McGill University Health Centre Research Institute.
Petrecca K; Division of Neurosurgery, McGill University Health Centre.
Owen S; Department of Oncology, McGill University Health Centre Research Institute.
Panet-Raymond V; Division of Radiation Oncology, Mcgill University Health Centre.
Shenouda G; Division of Radiation Oncology, Mcgill University Health Centre.
Souhami L; Division of Radiation Oncology, Mcgill University Health Centre.
Azam M; Centre for Translational Biology, The Research Institute of McGill University Health Centre, Montreal, Quebec, Canada.
Hossain B; Centre for Translational Biology, The Research Institute of McGill University Health Centre, Montreal, Quebec, Canada.
Alkass J; Centre for Translational Biology, The Research Institute of McGill University Health Centre, Montreal, Quebec, Canada.
Sabri S; Centre for Translational Biology, The Research Institute of McGill University Health Centre, Montreal, Quebec, Canada.
Abdulkarim B; Division of Radiation Oncology, Mcgill University Health Centre.